AAAAAA

   
Results: 1-17 |
Results: 17
Effects of statins on biomarkers of bone metabolism: A randomised trial
Authors: Stein, EA Farnier, M Waldstreicher, J Mercuri, M
Citation: Ea. Stein et al., Effects of statins on biomarkers of bone metabolism: A randomised trial, NUTR MET CA, 11(2), 2001, pp. 84-87
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
Authors: Kaplan, SA Holtgrewe, HL Bruskewitz, R Saltzman, B Mobley, D Narayan, P Lund, RH Weiner, S Wells, G Cook, TJ Meehan, A Waldstreicher, J
Citation: Sa. Kaplan et al., Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia, UROLOGY, 57(6), 2001, pp. 1073-1077
Development of a health-related quality of life questionnaire for women with androgenetic alopecia
Authors: Dolte, KS Girman, CJ Hartmaier, S Roberts, J Bergfeld, W Waldstreicher, J
Citation: Ks. Dolte et al., Development of a health-related quality of life questionnaire for women with androgenetic alopecia, CLIN EXP D, 25(8), 2000, pp. 637-642
Prostate volume and serum prostate-specific antigen as predictors of acuteurinary retention - Combined experience from three large multinational placebo-controlled trials
Authors: Marberger, MJ Andersen, JT Nickel, JC Malice, MP Gabriel, M Pappas, F Meehan, A Stoner, E Waldstreicher, J
Citation: Mj. Marberger et al., Prostate volume and serum prostate-specific antigen as predictors of acuteurinary retention - Combined experience from three large multinational placebo-controlled trials, EUR UROL, 38(5), 2000, pp. 563-568
Urinary retention in patients with BPH treated with finasteride or placeboover 4 years - Characterization of patients and ultimate outcomes
Authors: Roehrborn, CG Bruskewitz, R Nickel, GC Glickman, S Cox, C Anderson, R Kandzari, S Herlihy, R Kornitzer, G Brown, BT Holtgrewe, HL Taylor, A Wang, D Waldstreicher, J
Citation: Cg. Roehrborn et al., Urinary retention in patients with BPH treated with finasteride or placeboover 4 years - Characterization of patients and ultimate outcomes, EUR UROL, 37(5), 2000, pp. 528-536
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
Authors: Price, VH Roberts, JL Hordinsky, M Olsen, EA Savin, R Bergfeld, W Fiedler, V Lucky, A Whiting, DA Pappas, F Culbertson, J Kotey, P Meehan, A Waldstreicher, J
Citation: Vh. Price et al., Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia, J AM ACAD D, 43(5), 2000, pp. 768-776
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride
Authors: Kaplan, S Garvin, D Gilhooly, P Koppel, M Labasky, R Milsten, R Reddy, P Rosenberg, S Sussman, D White, C Lee, M Pappas, F Waldstreicher, J
Citation: S. Kaplan et al., Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride, UROLOGY, 56(4), 2000, pp. 610-616
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia
Authors: Roehrborn, CG McConnell, J Bonilla, J Rosenblatt, S Hudson, PB Malek, GH Schellhammer, PF Bruskewitz, R Matsumoto, AM Harrison, LH Fuselier, HA Walsh, P Roy, J Andriole, G Resnick, M Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia, J UROL, 163(1), 2000, pp. 13-20
Patient-perceived importance of negative effects of androgenetic alopecia in women
Authors: Girman, CJ Hartmaier, S Roberts, J Bergfeld, W Waldstreicher, J
Citation: Cj. Girman et al., Patient-perceived importance of negative effects of androgenetic alopecia in women, J WOMEN H G, 8(8), 1999, pp. 1091-1095
Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: Results of finasteride 1 mg treatment of men and postmenopausal women
Authors: Whiting, DA Waldstreicher, J Sanchez, M Kaufman, KD
Citation: Da. Whiting et al., Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: Results of finasteride 1 mg treatment of men and postmenopausal women, J INV D SYM, 4(3), 1999, pp. 282-284
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
Authors: Drake, L Hordinsky, M Fiedler, V Swinehart, J Unger, WP Cotterill, PC Thiboutot, DM Lowe, N Jacobson, C Whiting, D Stieglitz, S Kraus, SJ Griffin, EI Weiss, D Carrington, P Gencheff, C Cole, GW Pariser, DM Epstein, ES Tanaka, W Dallob, A Vandormael, K Geissler, L Waldstreicher, J
Citation: L. Drake et al., The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia, J AM ACAD D, 41(4), 1999, pp. 550-554
Finasteride in the treatment of men with frontal male pattern hair loss
Authors: Leyden, J Dunlap, F Miller, B Winters, P Lebwohl, M Hecker, D Kraus, S Baldwin, H Shalita, A Draelos, Z Markou, M Thiboutot, D Rapaport, M Kang, SW Kelly, T Pariser, D Webster, G Hordinsky, M Rietschel, R Katz, HI Terranella, L Best, S Round, E Waldstreicher, J
Citation: J. Leyden et al., Finasteride in the treatment of men with frontal male pattern hair loss, J AM ACAD D, 40(6), 1999, pp. 930-937
Serum prostate-specific antigen and prostate volume predict long-term chances in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo
Authors: Roehrborn, CG Boyle, P Bergner, D Gray, T Gittelman, M Shown, T Melman, A Bracken, RB White, RD Taylor, A Wang, D Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate-specific antigen and prostate volume predict long-term chances in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo, UROLOGY, 54(4), 1999, pp. 662-669
Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia
Authors: Bruskewitz, R Girman, CJ Fowler, J Rigby, OF Sullivan, M Bracken, RB Fusilier, HA Kozlowski, D Kantor, SD Johnson, EL Wang, DZ Waldstreicher, J
Citation: R. Bruskewitz et al., Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia, UROLOGY, 54(4), 1999, pp. 670-678
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
Authors: Yang, XJ Lecksell, K Short, K Gottesman, J Peterson, L Bannow, J Schellhammer, PF Fitch, WP Hodge, GB Parra, R Rouse, S Waldstreicher, J Epstein, JI
Citation: Xj. Yang et al., Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?, UROLOGY, 53(4), 1999, pp. 696-700
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
Authors: Roehrborn, CG McConnell, JD Lieber, M Kaplan, S Geller, J Malek, GH Castellanos, R Coffield, S Saltzman, B Resnick, M Cook, TJ Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 473-480
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
Authors: Roehrborn, CG Boyle, P Gould, AL Waldstreicher, J
Citation: Cg. Roehrborn et al., Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 581-589
Risultati: 1-17 |